Table 1. Patient characteristics.
|
Information of HRM and LRM breast cancer patients | ||||
|---|---|---|---|---|
| Characteristic |
HRM patients |
LRM patients |
||
| No. | (%) | No. | (%) | |
| Overall | 22 | 100.0 | 56 | 100.0 |
|
Age, years | ||||
| ⩽39 | 6 | 27.3 | 15 | 26.8 |
| 40–49 | 2 | 9.1 | 12 | 21.4 |
| 50–59 | 7 | 31.8 | 20 | 35.7 |
| ⩾60 | 7 | 31.8 | 9 | 16.1 |
|
Estrogen receptor status | ||||
| Positive | 10 | 45.5 | 24 | 42.9 |
| Negative | 12 | 54.5 | 32 | 57.1 |
|
Progesterone receptor status | ||||
| Positive | 9 | 40.9 | 20 | 35.7 |
| Negative | 13 | 59.1 | 36 | 64.3 |
|
HER2 status | ||||
| Positive | 3 | 13.6 | 7 | 12.5 |
| Negative/unknown | 19 | 86.4 | 49 | 87.5 |
|
Adjuvant hormonal treatment | ||||
| Yes | 8 | 36.4 | 28 | 50.0 |
| No/unknown | 14 | 63.6 | 28 | 50.0 |
|
Molecular subtype | ||||
| Luminal | 11 | 50.0 | 27 | 48.2 |
| TNBC | 7 | 31.8 | 18 | 32.1 |
| HER2 | 1 | 4.5 | 5 | 8.9 |
| Non-luminal | 3 | 13.6 | 6 | 10.7 |
Abbreviations: HRM, high risk for distant metastasis; LRM, low risk for distant metastasis.